Cara Therapeutics, Inc.

CARA
107 Elm St FL 9
Stamford, CT, 06902-3834  United States
(203) 406-3700
Company Type: Corporation Independent

Cara Therapeutics cares about pain therapy. The clinical-stage biopharmaceutical company focuses on developing and commercializing new chemical products designed to alleviate pain by selectively targeting kappa opioid receptors. Its proprietary class of product candidates target the body's peripheral nervous system. In test with patients with moderate-to-severe pain they have have demonstrated efficacy without inducing many of the undesirable side effects often associated with pain therapeutics. Cara's most advanced product candidate, is intravenous CR845. The company filed to go public in 2014.

Try D&B Hoovers Free

Financial Statements

Financial data as of December 31, 2019 (12 month period) in USD

Annual Revenue 2019
$19.89 million USD

Dun & Bradstreet collects private company financials for more than 23 million companies in over 200 countries. Find out more.

Competitor Profiles

See detailed profiles for insights and prospects on this company's top competitors.

Company Snapshot

Essential information for a successful call

  •  EMPLOYEES (All Sites) 37
  • ASSETS (MIL USD) 233
  •  REVENUE (MIL USD) 19.89
  • TICKER SYMBOL CARA
  • Incorporated 2004
  • FISCAL YEAR END DEC
  • SALES GROWTH % 47.64%

Get in Touch with 4 Contacts and 5 Principals*

A D&B Hoovers Subscription is your foot in the door to Cara Therapeutics, Inc. contact information.
  • Derek Chalmers
    President and Chief Executive Officer
  • MANI MOHINDRU
    Chief Financial Officer and Officer
  • FREDERIQUE MENZAGHI
    Senior Vice President
  • SCOTT M TERRILLION
    General Counsel and Secretary and Officer
See full contact details
Start Your Free Trial

Get full access to D&B Hoovers

With a Hoovers subscription you can get a comprehensive view of Cara Therapeutics, Inc.

Cara Therapeutics, Inc.*

4
Contacts
Reach the right people with access to detailed contact information.
5
Principals
See who the company's key decision makers are
9
Close Industry Peers
See similar companies for insight and prospecting.
*Contacts and Principals counts are estimates and may differ from the actual number of contacts available in D&B Hoovers.